These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28224315)

  • 1. Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.
    Andersson R; Kroon T; Almquist J; Jirstrand M; Oakes ND; Evans ND; Chappel MJ; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):203-222. PubMed ID: 28224315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats.
    Kroon T; Kjellstedt A; Thalén P; Gabrielsson J; Oakes ND
    J Lipid Res; 2015 Sep; 56(9):1679-90. PubMed ID: 26168997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S].
    Kroon T; Baccega T; Olsén A; Gabrielsson J; Oakes ND
    J Lipid Res; 2017 Jan; 58(1):31-41. PubMed ID: 27875257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.
    Ahlström C; Kroon T; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):623-38. PubMed ID: 24114415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response-time modelling: Second-generation turnover model with integral feedback control.
    Andersson R; Jirstrand M; Peletier L; Chappell MJ; Evans ND; Gabrielsson J
    Eur J Pharm Sci; 2016 Jan; 81():189-200. PubMed ID: 26529383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.
    Ahlström C; Peletier LA; Jansson-Löfmark R; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):1-24. PubMed ID: 21046209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.
    Tapani S; Almquist J; Leander J; Ahlström C; Peletier LA; Jirstrand M; Gabrielsson J
    J Pharm Sci; 2014 Aug; 103(8):2571-84. PubMed ID: 24986056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.
    Ahlström C; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):497-512. PubMed ID: 23824920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue.
    Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
    Blachère JC; Pérusse F; Bukowiecki LJ
    Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging the dose-response-time data approach: Analysis of a complex system.
    Andersson R; Jirstrand M; Almquist J; Gabrielsson J
    Eur J Pharm Sci; 2019 Feb; 128():250-269. PubMed ID: 30453011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
    Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
    Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
    Reaven GM; Chang H; Hoffman BB
    Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can associations between free fatty acid levels and metabolic parameters determine insulin resistance development in obese Zucker rats?
    Abadie JM; Malcom GT; Porter JR; Svec F
    Life Sci; 2001 Oct; 69(22):2675-83. PubMed ID: 11712670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
    Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
    Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo.
    Mayorek N; Kalderon B; Itach E; Bar-Tana J
    Diabetes; 1997 Dec; 46(12):1958-64. PubMed ID: 9392480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
    Dhalla AK; Santikul M; Chisholm JW; Belardinelli L; Reaven GM
    Diabetes Obes Metab; 2009 Feb; 11(2):95-101. PubMed ID: 18494808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose Tissue Free Fatty Acid Storage In Vivo: Effects of Insulin Versus Niacin as a Control for Suppression of Lipolysis.
    Ali AH; Mundi M; Koutsari C; Bernlohr DA; Jensen MD
    Diabetes; 2015 Aug; 64(8):2828-35. PubMed ID: 25883112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.